Trial intelligence / Profile preview

Celecoxib vs. Tramadol in Chronic Low Back Pain

NCT00662558Phase 3Completed

Sponsor
Viatris
Start
Jan 2008
Primary completion
Sep 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of celecoxib in low back pain (LBP), sponsored by Viatris. Primary endpoint: Treatment Responders Based on the Numerical Rating Scale-Pain at 6 weeks. Started Jan 2008; status: completed.

02

Drugs

celecoxib
03

Conditions

low back pain (LBP)

Beyond the preview

Go deeper on NCT00662558.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00662558.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call